Amy L. Cox

1.1k total citations
20 papers, 721 citations indexed

About

Amy L. Cox is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Amy L. Cox has authored 20 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Surgery and 4 papers in Oncology. Recurrent topics in Amy L. Cox's work include Drug Transport and Resistance Mechanisms (3 papers), Pancreatic function and diabetes (3 papers) and Adipose Tissue and Metabolism (2 papers). Amy L. Cox is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pancreatic function and diabetes (3 papers) and Adipose Tissue and Metabolism (2 papers). Amy L. Cox collaborates with scholars based in United States. Amy L. Cox's co-authors include Kyle W. Sloop, James Ficorilli, M. Dodson Michael, Aaron D. Showalter, Laura F. Michael, Michael J. Coghlan, Kevin L. Duffin, Axel Haupt, Jonathan M. Wilson and Martin Brenner and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Biotechnology.

In The Last Decade

Amy L. Cox

19 papers receiving 694 citations

Peers

Countries citing papers authored by Amy L. Cox

Since Specialization

Citations

This map shows the geographic impact of Amy L. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy L. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy L. Cox more than expected).

Fields of papers citing papers by Amy L. Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy L. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy L. Cox. The network helps show where Amy L. Cox may publish in the future.

Co-authorship network of co-authors of Amy L. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Amy L. Cox. A scholar is included among the top collaborators of Amy L. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy L. Cox. Amy L. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site 2022 ·Molecular Metabolism ·(unknown), Chad D. Paavola, Konstantin Maslov, (unknown), (unknown), Amy L. Cox, Rui Cao, Junhui Shi, Patricia Brown‐Augsburger, (unknown), Ross L. Blankenship, (unknown), Scott A. Bradley, John M. Beals, Sunday S. Oladipupo, Lihong V. Wang	13
2	Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam 2022 ·Journal of Controlled Release ·Yun‐Chu Chen, Dana E. Moseson, (unknown), (unknown), Sarena D. Horava, (unknown), Amy L. Cox, Eric D. Hawkins, (unknown), (unknown), (unknown), (unknown), L. Tiffany Lyle, Eric J. Munson, Lynne S. Taylor, Kinam Park, Yoon Yeo	18
3	Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam 2022 ·Journal of Controlled Release ·Yihua Pei, Jianping Wang, Nisar Ul Khaliq, Fanfei Meng, (unknown), Jie Xue, Sarena D. Horava, Amy L. Cox, (unknown), (unknown), Kinam Park, Yoon Yeo	8
4	The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A p ost hoc analysis 2021 ·Diabetes Obesity and Metabolism ·Jonathan M. Wilson, Yanzhu Lin, Mengdie Luo, (unknown), Amy L. Cox, (unknown), Deborah A. Robins, Axel Haupt, Kevin L. Duffin, Giacomo Ruotolo	89
5	Insulin, Not the Preservative m-cresol, Instigates Loss of Infusion Site Patency Over Extended Durations of CSII in Diabetic Swine 2020 ·Journal of Pharmaceutical Sciences ·(unknown), Amy L. Cox, Eric D. Hawkins, Jie Xue, Parag Garhyan, James R. L. Stanley, (unknown), (unknown), M. Dodson Michael	10
6	Abstract 13426: The Dual GIP/GLP-1 Receptor Agonist Tirzepatide Improves Cardiovascular Risk Protein Biomarkers in Patients With Type 2 Diabetes 2020 ·Circulation ·Jonathan M. Wilson, Yanzhu Lin, (unknown), Amy L. Cox, (unknown), Deborah A. Robins, Jeffrey S. Riesmeyer, Axel Haupt, Kevin L. Duffin, Giacomo Ruotolo	1
7	β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy 2016 ·Endocrinology ·Darline Garibay, Anne K. McGavigan, Seon A Lee, James Ficorilli, Amy L. Cox, M. Dodson Michael, Kyle W. Sloop, Bethany P. Cummings	49
8	Characterization and Quantification of Oxyntomodulin in Human and Rat Plasma Using High-Resolution Accurate Mass LC–MS 2016 ·Bioanalysis ·Jennifer Cox, Michael J. Berna, Zhiying Jin, Amy L. Cox, Kyle W. Sloop, Jesus A. Gutierrez, Bradley L. Ackermann	15
9	Fully Implantable Arterial Blood Glucose Device for Metabolic Research Applications in Rats for Two Months 2015 ·Journal of Diabetes Science and Technology ·(unknown), (unknown), (unknown), (unknown), (unknown), Libbey S. O′Farrell, (unknown), Amy L. Cox, Tamer Coşkun	17
10	Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia 2015 ·Journal of Medicinal Chemistry ·Michaël Génin, Ana B. Bueno, (unknown), Peter R. Manninen, Wayne P. Bocchinfuso, Chahrzad Montrose‐Rafizadeh, Ellen A. Cannady, Timothy M. Jones, John R. Stille, Eyas Raddad, Charles A. Reidy, Amy L. Cox, (unknown), Laura F. Michael	52
11	Comparative Pharmacokinetics Studies of Immediate- and Modified-Release Formulations of Glipizide in Pigs and Dogs 2012 ·Journal of Pharmaceutical Sciences ·(unknown), Nathan Yumibe, Zhongyi Wang, Xin Zhang, Cheng Tang, Kenneth J. Ruterbories, Amy L. Cox, (unknown), Gregory T. Knipp	10
12	Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets 2010 ·Diabetes ·Kyle W. Sloop, Francis S. Willard, Martin Brenner, James Ficorilli, (unknown), Aaron D. Showalter, Thomas B. Farb, (unknown), Amy L. Cox, (unknown), (unknown), Mark J. Tebbe, Michael J. Coghlan	121
13	The Effects of Weighted Vests on Appropriate In-Seat Behaviors of Elementary-Age Students With Autism and Severe to Profound Intellectual Disabilities 2008 ·Focus on Autism and Other Developmental Disabilities ·Amy L. Cox, David L. Gast, Deanna Luscre, Kevin M. Ayres	31
14	Specific Reduction of Hepatic Glucose 6-Phosphate Transporter-1 Ameliorates Diabetes while Avoiding Complications of Glycogen Storage Disease 2007 ·Journal of Biological Chemistry ·Kyle W. Sloop, Aaron D. Showalter, Amy L. Cox, (unknown), Angela M. Siesky, Hongyan Zhang, Armando R. Irizarry, Susan F. Murray, Sheri Booten, (unknown), Robert A. McKay, Brett P. Monia, Sanjay Bhanot, M. Dodson Michael	10
15	Farnesoid X Receptor Agonist Reduces Serum Asymmetric Dimethylarginine Levels through Hepatic Dimethylarginine Dimethylaminohydrolase-1 Gene Regulation 2006 ·Journal of Biological Chemistry ·(unknown), Michael Chouinard, Amy L. Cox, (unknown), (unknown), James Ficorilli, Shuyu Li, Hong Gao, Timothy P. Ryan, M. Dodson Michael, Laura F. Michael	73
16	Reduction of Hepatic and Adipose Tissue Glucocorticoid Receptor Expression With Antisense Oligonucleotides Improves Hyperglycemia and Hyperlipidemia in Diabetic Rodents Without Causing Systemic Glucocorticoid Antagonism 2005 ·Diabetes ·Lynnetta M. Watts, Vara Prasad Manchem, (unknown), (unknown), Robert A. McKay, Dingjiu Bao, (unknown), Brett P. Monia, Diane Bodenmiller, (unknown), Hongyan Zhang, Amy L. Cox, Steven J. Jacobs, (unknown), Kyle W. Sloop, Sanjay Bhanot	111
17	Hybrid insulin cocrystals for controlled release delivery 2002 ·Nature Biotechnology ·Mark L. Brader, Muppalla Sukumar, Allen H. Pekar, (unknown), Ronald E. Chance, David B. Flora, Amy L. Cox, (unknown), Sharon R Myers	67
18	Determining Oxidation-Reduction on a Simple Number Line 2002 ·Journal of Chemical Education ·Amy L. Cox, James R. Cox	3
19	New Buffalo: Tribal Gaming as a Means of Subsistence Under Attack 1998 ·Boston College environmental affairs law review ·Amy L. Cox	1
20	Effects of mianserin and ketanserin on lordosis behavior after systemic treatment or infusion into the ventromedial nucleus of the hypothalamus 1996 ·Brain Research ·Lynda Uphouse, (unknown), Amy L. Cox, Marjay Caldarola-Pastuszka, Amy Wolf	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact